Form 8-K · Current report
Occidental Petroleum 8-K, filed Oct 13, 2026
- Filed
- CIK
- 0000797468
- Accession no.
- 0001628280-26-065586
Summary
Occidental Petroleum provided third-quarter 2026 earnings considerations, saying total company production was within its guidance range despite temporary Gulf of America curtailments caused by a third-party gas pipeline constraint and maintenance. The company also gave preliminary estimates for volumes, costs, realized prices, and hedging impacts, including a $94 million negative cash flow effect from crude oil collar settlements.
Key points
- Occidental said third-quarter 2026 total company production was within its guidance range.
- In September, Occidental temporarily curtailed production at certain Gulf of America facilities due to a third-party gas pipeline constraint and maintenance, with production partially restored and remaining impacted production expected to return as the constraint is resolved.
- Occidental estimated third-quarter 2026 Gulf of America net sales volumes at 110 Mboed, domestic lease operating cost at $8.54/boe, and total company oil production at 48.8%.
- Crude oil collar settlements negatively impacted third-quarter 2026 operating cash flow before working capital by $94 million; total worldwide realized oil prices averaged $85.91/bbl.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 13, 2026, Occidental Petroleum Corporation (the "Company") provided a summary of factors management believes will impact the Company's third quarter of 2026 results (the "Earnings Considerations"). A copy of the Earnings Considerations is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in this report and in Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be incorporated by reference into any filings made by the Company under the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.